Advertisement Aptalis Pharmaceutical Technologies Sponsors AAPS Research Achievement Awards in Pharmacokinetics, Pharmacodynamics and Drug Metabolism at AAPS Annual Meeting and Exposition - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about

Aptalis Pharmaceutical Technologies Sponsors AAPS Research Achievement Awards in Pharmacokinetics, Pharmacodynamics and Drug Metabolism at AAPS Annual Meeting and Exposition

The 2012 annual meeting and exposition is an international forum for the exchange of knowledge among an expected 9,000 attendees, including scientists working in drug design, discovery, development, delivery, packaging, scaleup, clinical trials, and regulatory sciences.

AAPS Research Achievement Awards

The AAPS Research Achievement Awards are intended to recognize outstanding scientists who have conducted fundamental research that has had significant impact in the fields of Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM).

Aptalis Pharmaceutical Technologies is the sponsor of the 2012 awards being presented during AAPS’ annual meeting and exposition October 14-18 in Chicago. PPDM is the section of the American Association of Pharmaceutical Scientists that provides an opportunity for the presentation of new data and an exchange of ideas by individuals actively engaged in the various facets of pharmacokinetics, pharmacodynamics, drug metabolism, transport, biopharmaceutics, and related sciences.

Aptalis APPS Poster Presentation and Recruitment

Meeting participants are invited to visit the Aptalis Pharmaceutical Technologies’ poster presentation: T2132, "Development of orally disintegrating tablets comprising controlledrelease multiparticulate beads." P.J. Stevens, G. Venkatesh, J. Lai, October 16, 2012, Hall F, McCormick Place 9:30 a.m. to 12:30 p.m. and to visit the Aptalis Career Center Booth # CC1.